PAR 1.92% 25.5¢ paradigm biopharmaceuticals limited..

Ann: 2021 Annual Report and Appendix 4E, page-79

  1. 85 Posts.
    lightbulb Created with Sketch. 21

    Thanks again for your input. Much appreciated.
    Thanks again Mozz as usual! Are you saying that the slower uptake of iPPS in humans is of benefit due to the fact that therefore it is also likely to stay circulating in the body for longer and that subcut takes longer to be excreted by the kidneys? Just interested to see why they have made these decisions. Really probably only playing in the margins here but I suppose everything counts!

    In other news. Loving the green today. Not sure why, 'another' insider leak perhaps? Just speculating of course
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
25.5¢
Change
-0.005(1.92%)
Mkt cap ! $89.19M
Open High Low Value Volume
27.0¢ 27.0¢ 25.5¢ $261.4K 990.7K

Buyers (Bids)

No. Vol. Price($)
1 9999 25.5¢
 

Sellers (Offers)

Price($) Vol. No.
26.0¢ 9445 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.